Image‐guided method for TLD‐based in vivo rectal dose verification with endorectal balloon in proton therapy for prostate cancer
Authors:
- Wen C. HsiWHWen C. Hsi
- Marcio FagundesMFMarcio Fagundes
- Omar ZeidanOZOmar Zeidan
- Eugen HugEHEugen Hug
- Niek SchreuderNSNiek Schreuder
Open Access
- 26 April 2013
- journal article
- Published by Wiley in Medical Physics
- Vol. 40 (5) , 051715
Abstract
Purpose:: To present a practical image‐guided method to position an endorectal balloon that improvesin vivo thermoluminiscent dosimeter (TLD) measurements of rectal doses in proton therapy for prostate cancer.Methods:: TLDs were combined with endorectal balloons to measure dose at the anterior rectal wall during daily proton treatment delivery. Radiopaque metallic markers were employed as surrogates for balloon position reproducibility in rotation and translation. The markers were utilized to guide the balloon orientation during daily treatment employing orthogonal x‐ray image‐guided patient positioning. TLDs were placed at the 12 o'clock position on the anterior balloon surface at the midprostatic plane. Markers were placed at the 3 and 9 o'clock positions on the balloon to align it with respect to the planned orientation. The balloon rotation along its stem axis, referred to as roll, causes TLD displacement along the anterior‐posterior direction. The magnitude of TLD displacement is revealed by the separation distance between markers at opposite sides of the balloon on sagittal x‐ray images.Results:: A total of 81in vivo TLD measurements were performed on six patients. Eighty‐three percent of all measurements (65 TLD readings) were within +5% and −10% of the planning dose with a mean of −2.1% and a standard deviation of 3.5%. Examination of marker positions with in‐room x‐ray images of measured doses between −10% and −20% of the planned dose revealed a strong correlation between balloon roll and TLD displacement posteriorly from the planned position. The magnitude of the roll was confirmed by separations of 10–20 mm between the markers which could be corrected by manually adjusting the balloon position and verified by a repeat x‐ray image prior to proton delivery. This approach could properly correct the balloon roll, resulting in TLD positioning within 2 mm along the anterior‐posterior direction.Conclusions:: Our results show that image‐guided TLD‐basedin vivo dosimetry for rectal dose verification can be perfomed reliably and reproducibly for proton therapy in prostate cancer.Keywords
This publication has 7 references indexed in Scilit:
- Effectiveness of a novel gas-release endorectal balloon in the removal of rectal gas for prostate proton radiation therapyJournal of Applied Clinical Medical Physics, 2012
- Implanted Dosimeters Identify Radiation Overdoses During IMRT for Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Improvement of Prostate Treatment by Anterior Proton FieldsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Toward a Real-Time In Vivo Dosimetry System Using Plastic Scintillation DetectorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- LiF TLD-100 as a Dosimeter in High Energy Proton Beam Therapy—Can It Yield Accurate Results?Medical Dosimetry, 2010
- A practical method to achieve prostate gland immobilization and target verification for daily treatmentInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- Application of solid state detectors for dosimetry of therapeutic proton beamsMedical Physics, 1995